
Trump Strategy to Rein In Drug Prices Revives ‘Most-Favored Nation’ Plan of His First Term
President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries.